Breast Cancer Surveillance Consortium receives $7.5 million to investigate supplemental breast MRI and tomosynthesis.
A new video shows how patient engagement takes center stage in Dr. Karen Wernli’s study of breast cancer imaging for women who’ve had the disease before.
See how 2015 was the Institute’s best year yet—for funding and practical impact, improving people’s health at Group Health and across the country.
Dr. Diana Buist explains the new Breast Cancer Surveillance Consortium study in JAMA Oncology, which she co-wrote.
Based on a new BCSC study, Dr. Diana Buist tells of technology that adds cost to breast cancer screening—without improving outcomes. Dr. Marc Mora comments.
CAD raises screening costs without benefit to patients and may miss cancers, large national BCSC study shows.
A Breast Cancer Surveillance Consortium study involving Group Health shows that density shouldn’t be the only factor when considering additional screening.